A detailed history of Wellington Management Group LLP transactions in Myriad Genetics Inc stock. As of the latest transaction made, Wellington Management Group LLP holds 6,716,583 shares of MYGN stock, worth $104 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
6,716,583
Previous 8,262,425 18.71%
Holding current value
$104 Million
Previous $202 Million 9.04%
% of portfolio
0.03%
Previous 0.04%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$23.97 - $28.6 $37.1 Million - $44.2 Million
-1,545,842 Reduced 18.71%
6,716,583 $184 Million
Q2 2024

Aug 13, 2024

BUY
$17.98 - $25.47 $3.64 Million - $5.16 Million
202,424 Added 2.51%
8,262,425 $202 Million
Q1 2024

May 15, 2024

BUY
$17.59 - $23.59 $142 Million - $190 Million
8,060,001 New
8,060,001 $172 Million
Q4 2023

Feb 12, 2024

BUY
$13.91 - $21.32 $100 Million - $154 Million
7,219,706 New
7,219,706 $138 Million
Q3 2023

Nov 14, 2023

BUY
$15.99 - $23.22 $4.02 Million - $5.84 Million
251,426 Added 4.38%
5,996,260 $96.2 Million
Q2 2023

Aug 14, 2023

SELL
$17.56 - $23.76 $17.3 Million - $23.4 Million
-986,005 Reduced 14.65%
5,744,834 $133 Million
Q1 2023

May 12, 2023

SELL
$15.26 - $23.75 $860,419 - $1.34 Million
-56,384 Reduced 0.83%
6,730,839 $156 Million
Q4 2022

Feb 13, 2023

BUY
$14.51 - $20.99 $12 Million - $17.3 Million
824,001 Added 13.82%
6,787,223 $98.5 Million
Q3 2022

Nov 14, 2022

BUY
$18.21 - $27.88 $8.75 Million - $13.4 Million
480,696 Added 8.77%
5,963,222 $114 Million
Q2 2022

Aug 15, 2022

BUY
$16.45 - $25.88 $6.35 Million - $10 Million
386,291 Added 7.58%
5,482,526 $99.6 Million
Q1 2022

May 16, 2022

BUY
$22.67 - $28.01 $17.5 Million - $21.6 Million
770,460 Added 17.81%
5,096,235 $128 Million
Q4 2021

Feb 11, 2022

BUY
$24.13 - $32.63 $26.4 Million - $35.7 Million
1,094,563 Added 33.87%
4,325,775 $119 Million
Q3 2021

Nov 15, 2021

BUY
$29.97 - $36.66 $67.1 Million - $82 Million
2,238,076 Added 225.35%
3,231,212 $104 Million
Q2 2021

Aug 16, 2021

BUY
$25.39 - $32.61 $2.9 Million - $3.72 Million
114,202 Added 12.99%
993,136 $30.4 Million
Q1 2021

May 17, 2021

BUY
$19.92 - $31.6 $17.5 Million - $27.8 Million
878,934 New
878,934 $26.8 Million
Q1 2020

May 14, 2020

SELL
$9.78 - $29.53 $162,817 - $491,615
-16,648 Closed
0 $0
Q4 2019

Feb 11, 2020

BUY
$20.93 - $35.1 $348,442 - $584,344
16,648 New
16,648 $454,000

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.25B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.